JodiIanLuchsMD

Ophthalmology • Stuart, FL

Anterior Segment Related, Cataract Related, Cornea & External Disease, Refractive Surgery

Director of Cornea/External Disease: Florida Vision Institute; Chief Science Advisor: InFocus Capital Partners; Director: Stuart Therapeutics

Join to view full profile

Dr. Luchs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Luchs' full profile

Already have an account?

Office
1050 SE Monterey Rd
Ste 104
Stuart, FL 34994
Phone+1 772-283-2020

Fax+1 772-220-9582
Is this information wrong?

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Cornea, External Diseases, and Refractive Surgery, 1995 - 1996
Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1992 - 1995
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1991 - 1992
Albert Einstein College of MedicineClass of 1991
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Wills Eye Hospital

Certifications & Licensure

NY State Medical License 1992 - 2026
FL State Medical License 2018 - 2025
PA State Medical License 1995 - 1996
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Achievement Award American Academy of Ophthalmology, 2017
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes Start of enrollment: 2007 May 01
Completed
Phase 4
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis Start of enrollment: 2009 Jun 01
Completed
Not Applicable
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas Start of enrollment: 2010 Feb 01
Terminated
Dry Eye Assessment and Management Study Start of enrollment: 2014 Nov 01
Completed
Phase 3
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2014 Jun 01
Completed
Phase 2
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Start of enrollment: 2014 Jul 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.
Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina, Brittany Mitchell, Jodi I Luchs> ;Clinical Ophthalmology. 2022 Jan 1
5 citations
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.
John D. Sheppard, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, Abayomi Ogundele, Paul M. Karpecki> ;Clinical Ophthalmology. 2021 Jan 12
5 citations
Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture.
Kenneth A Beckman, Mark S. Milner, Parag A. Majmudar, Jodi Luchs> ;American Journal of Ophthalmology Case Reports. 2020 Jun 1
Changes in preoperative corneal measurements following same-day intraocular pressure testing with rebound tonometry.
Kenneth A Beckman, Jodi Luchs, Mark S. Milner, Richard W Yee> ;Therapeutic Advances in Ophthalmology. 2020 Jan 22
19 citations
Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies.
Bridgitte Shen Lee, Alan G Kabat, Jason Bacharach, Paul M. Karpecki, Jodi Luchs> ;Clinical Ophthalmology. 2020 Jan 14
11 citations
Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 an...
John Sheppard, Shane R Kannarr, Jodi Luchs, Ranjan Malhotra, Angela Justice, Abayomi Ogundele, Charles Darby, Jason Bacharach> ;Eye & Contact Lens. 2020 Jan 1
46 citations
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
Sanjay Asrani, Alan L. Robin, Janet B. Serle, Richard A Lewis, Dale W Usner, Casey Kopczynski, Theresa Heah, Stacey L. Ackerman, Louis M. Alpern, Kent Bashford, Ettale...> ;American Journal of Ophthalmology. 2019 Nov 1
16 citations
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3...
Ranjan Malhotra, Douglas K Devries, Jodi Luchs, Alan G Kabat, Barry A. Schechter, Bridgitte Shen Lee, Lee Shettle, Robert Smyth-Medina, Abayomi Ogundele, Charles Darby...> ;Cornea. 2019 Oct 1
9 citations
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase...
Robert Smyth-Medina, Josh Johnston, Douglas K Devries, April L Jasper, Shane R Kannarr, Barry A Schechter, Bridgitte Shen Lee, George Varghese, Abayomi Ogundele, Charl...> ;Journal of Ocular Pharmacology and Therapeutics. 2019 Sep 5
10 citations
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
Elizabeth Yeu, Damien F Goldberg, Francis S. Mah, Kenneth A Beckman, Jodi Luchs, Jonathan D. Solomon, Darrell E White, Preeya K. Gupta> ;Clinical Ophthalmology. 2019 May 27
34 citations
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
Joseph Tauber, Barry A Schechter, Jason Bacharach, Melissa M Toyos, Robert Smyth-Medina, Sidney L Weiss, Jodi Luchs> ;Clinical Ophthalmology. 2018 Oct 2
Re: Keen et al.: Treatment of acute conjunctivitis in the United States and evidence of antibiotic overuse: isolated issue or a systematic problem? (Ophthalmology. 201...
Shachar Tauber, William Trattler, Christopher E. Starr, Marguerite B. McDonald, Jodi Luchs, Thomas Boland> ;Ophthalmology. 2018 Jul 1
20 citations
The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren’s Syndrome Diagnosis
Kenneth A Beckman, Jodi Luchs, Mark S. Milner> ;Advances in Therapy. 2017 Mar 10
123 citations
Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).
Edward J. Holland, Jodi Luchs, Paul M. Karpecki, Kelly K. Nichols, Mitchell A Jackson, Kenneth N Sall, Joseph Tauber, Monica Roy, Aparna Raychaudhuri, Amir H. Shojaei> ;Ophthalmology. 2017 Jan 1
112 citations
Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment
Mark S. Milner, Kenneth A Beckman, Jodi Luchs, Quentin B. Allen, Richard M. Awdeh, John P. Berdahl, Thomas Boland, Carlos Buznego, Joseph P Gira, Damien F Goldberg, Da...> ;Current Opinion in Ophthalmology. 2017 Jan 1
34 citations
Making the diagnosis of Sjögren’s syndrome in patients with dry eye
Kenneth A Beckman, Jodi Luchs, Mark S. Milner> ;Clinical Ophthalmology. 2015 Dec 24
119 citations
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Joseph Tauber, Paul M. Karpecki, Robert Latkany, Jodi Luchs, Joseph N. Martel, Kenneth N Sall, Aparna Raychaudhuri, Valerie L. Smith, Charles P. Semba> ;Ophthalmology. 2015 Dec 1
32 citations
Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis
Robert Sambursky, William Trattler, Shachar Tauber, Christopher E. Starr, Murray Friedberg, Thomas Boland, Marguerite B. McDonald, Michael DellaVecchia, Jodi Luchs> ;JAMA Ophthalmology. 2013 Jan 1
34 citations
Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry.
Jodi Luchs, Donald S Nelinson, Jonathan I Macy> ;Cornea. 2010 Dec 1
31 citations
Azithromycin in DuraSite® for the treatment of blepharitis
Jodi Luchs> ;Clinical Ophthalmology. 2010 Jun 28
78 citations
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis.
Jodi Luchs> ;Advances in Therapy. 2008 Sep 9
46 citations
Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis.
Vincent A. Deramo, James C. Lai, Jules Winokur, Jodi Ian Luchs, Ira J Udell> ;American Journal of Ophthalmology. 2008 Mar 1
7 citations
Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.
William Trattler, Jodi Luchs, Parag A. Majmudar> ;International Ophthalmology Clinics. 2006 Jan 1
174 citations
Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
Ann C. Guidera, Jodi I Luchs, Ira J. Udell> ;Ophthalmology. 2001 May 1
Comparing videokeratoscopic systems.
David Varssano, Christopher J. Rapuano, Jodi Luchs> ;Cornea. 1999 May 1
Join now to see all

Press Mentions

FDA OKs New Dry Eye TreatmentAugust 20th, 2018
Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye DiseaseAugust 16th, 2018

Professional Memberships